1
|
Joiner M, van der Kogel A and Steel G:
Introduction: the significance of radiobiology and radiotherapy for
cancer treatment. Basic Clinical Radiobiology. 4th edition. Joiner
and van der Kogel A: University Press/Hodder; Arnold, Oxford: pp.
1–10. 2009, View
Article : Google Scholar
|
2
|
Haveman J, Castro Kreder N, Rodermond HM,
Franken NA, Stalpers LJ, Zdzienicka MZ and Peters GJ: Cellular
response of X-ray sensitive hamster mutant cell lines to
gemcitabine, cisplatin and 5-fluorouracil. Oncol Rep. 12:187–192.
2004.PubMed/NCBI
|
3
|
Bergs JWJ, Franken NA, ten Cate R, van
Bree C and Haveman J: Effect of cisplatin and gamma irradiation on
cell survival, the induction of chromosomal aberrations and
apoptosis in SW-1573 cells. Mutat Res. 594:148–154. 2006.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Bergs JWJ, Franken NA, Haveman J, Geijsen
ED, Crezee J and van Bree C: Hyperthermia, cisplatin and radiation
trimodality treatment: a promising cancer treatment? A review from
preclinical studies to clinical application. Int J Hyperthermia.
23:329–341. 2007. View Article : Google Scholar
|
5
|
Franken NA, van Bree C, Kipp JBA and
Barendsen GW: Modification of potentially lethal damage in
irradiated Chinese hamster V79 cells after incorporation of
halogenated pyrimidines. Int J Radiat Biol. 72:101–109. 1997.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Franken NA, van Bree C, Veltmaat MAT,
Rodermond HM, Haveman J and Barendsen GW: Radiosensitization by
bromodeoxyuridine and hyperthermia: Analysis of linear and
quadratic parameters of radiation survival curves of two human
tumor cell lines. J Radiat Res. 42:179–190. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Iliakes G, Pantelias and Okayasu R:
Mechanism of radiosensitization by halogenated pyrimidines: effect
of BrdU on radiation induction of DNA and chromosome damage and its
correlation with cell killing. Radiat Res. 119:286–304. 1989.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Franken NA, van Bree C, Veltmaat MA,
Ludwików G, Kipp JB and Barendsen GW: Increased chromosome exchange
frequencies in iodo-deoxyuridine-sensitized human SW-1573 cells
after γ-irradiation. Oncol Rep. 6:59–63. 1999.PubMed/NCBI
|
9
|
Squatrito M, Gorrini C and Amati B: Tip60
in DNA damage response and growth control: many tricks in one HAT.
Trends Cell Biol. 16:433–442. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Luger K, Mäder AW, Richmond RK, Sargent DF
and Richmond TJ: Crystal structure of the nucleosome core particle
at 2.8 Å resolution. Nature. 389:251–260. 1997.
|
11
|
Kouzarides Tony: Chromatin modifications
and their function. Cell. 128:693–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Shahbazian MD and Grunstein M: Functions
of site-specific histone acetylation and deacetylation. Annu Rev
Biochem. 76:75–100. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kristensen LS, Nielsen HM and Hansen LL:
Epigenetics and cancer treatment. Eur J Pharmacol. 625:131–142.
2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Lee KK and Workman JL: Histone
acetyltransferase complexes: one size doesn’t fit all. Nat Rev Mol
Cell Biol. 8:284–295. 2007.PubMed/NCBI
|
15
|
Dekker FJ and Haisma HJ: Histone acetyl
transferases as emerging drug targets. Drug Discov Today.
14:942–948. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Balasubramanyam K, Swaminathan V,
Ranganathan A and Kundu TK: Small molecule modulators of histone
acetyltransferase p300. J Biol Chem. 278:19134–19140. 2003.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Sun Y, Jiang X, Chen S and Price BD:
Inhibition of histone acetyltransferase activity by anacardic acid
sensitizes tumor cells to ionizing radiation. FEBS Lett.
580:4353–4356. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Sun Y, Jiang X, Chen S, Fernandes N and
Price BD: A role for the Tip60 histone acetyltransferase in the
acetylation and activation of ATM. Proc Natl Acad Sci.
102:13182–13187. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Ikura T, Ogryzko VV, Grigoriev M, Groisman
R, Wang J, Horikoshi M, Scully R, Qin J and Nakatani Y: Involvement
of the Tip60 histone acetylase complex in DNA repair and apoptosis.
Cell. 102:463–473. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Goodarzi AA, Noon AT and Jeggo PA: The
impact of heterochromatin on DSB repair. Biochem Soc Trans.
37:569–576. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Biade S, Stobbe CC, Boyd JT and Chapman
JD: Chemical agents that promote chromatin compaction
radiosensitize tumour cells. Int J Radiat Biol. 77:1033–1042. 2001.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Franken NA, Rodermond HR, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar : PubMed/NCBI
|
23
|
Barendsen GW: Parameters of
linear-quadratic radiation dose-effect relationships: dependence on
LET and mechanisms of reproductive cell death. Int J Radiat Biol.
71:649–655. 1997. View Article : Google Scholar : PubMed/NCBI
|
24
|
Barendsen GW, van Bree C and Franken NA:
Importance of cell proliferative state and potentially lethal
damage repair on radiation effectiveness: implications for combined
tumor treatments. Int J Oncol. 19:247–256. 2001.
|
25
|
Song S, McCann KE and Brown JM:
Radiosensitization of yeast cells by inhibition of histone H4
acetylation. Radiat Res. 170:618–627. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Bandyopadhyay K, Banères JL, Martin A,
Blonski C, Parello J and Gjerset RA: Spermidinyl-CoA-based HAT
inhibitors block DNA repair and provide cancer-specific chemo- and
radiosensitization. Cell Cycle. 8:2779–2788. 2009. View Article : Google Scholar : PubMed/NCBI
|